383 related articles for article (PubMed ID: 17237937)
21. Beta amyloid deposition and neurofibrillary tangles spontaneously occur in the brains of captive cheetahs (Acinonyx jubatus).
Serizawa S; Chambers JK; Une Y
Vet Pathol; 2012 Mar; 49(2):304-12. PubMed ID: 21712514
[TBL] [Abstract][Full Text] [Related]
22. Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome.
Cataldo AM; Petanceska S; Terio NB; Peterhoff CM; Durham R; Mercken M; Mehta PD; Buxbaum J; Haroutunian V; Nixon RA
Neurobiol Aging; 2004; 25(10):1263-72. PubMed ID: 15465622
[TBL] [Abstract][Full Text] [Related]
23. Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization.
LaFerla FM; Troncoso JC; Strickland DK; Kawas CH; Jay G
J Clin Invest; 1997 Jul; 100(2):310-20. PubMed ID: 9218507
[TBL] [Abstract][Full Text] [Related]
24. A fibril-specific, conformation-dependent antibody recognizes a subset of Abeta plaques in Alzheimer disease, Down syndrome and Tg2576 transgenic mouse brain.
Sarsoza F; Saing T; Kayed R; Dahlin R; Dick M; Broadwater-Hollifield C; Mobley S; Lott I; Doran E; Gillen D; Anderson-Bergman C; Cribbs DH; Glabe C; Head E
Acta Neuropathol; 2009 Oct; 118(4):505-17. PubMed ID: 19360426
[TBL] [Abstract][Full Text] [Related]
25. Diminished parkin solubility and co-localization with intraneuronal amyloid-β are associated with autophagic defects in Alzheimer's disease.
Lonskaya I; Shekoyan AR; Hebron ML; Desforges N; Algarzae NK; Moussa CE
J Alzheimers Dis; 2013; 33(1):231-47. PubMed ID: 22954671
[TBL] [Abstract][Full Text] [Related]
26. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
[TBL] [Abstract][Full Text] [Related]
27. The Relevance of Amyloid β-Calmodulin Complexation in Neurons and Brain Degeneration in Alzheimer's Disease.
Poejo J; Salazar J; Mata AM; Gutierrez-Merino C
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34067061
[TBL] [Abstract][Full Text] [Related]
28. Brain-reactive autoantibodies prevalent in human sera increase intraneuronal amyloid-β(1-42) deposition.
Nagele RG; Clifford PM; Siu G; Levin EC; Acharya NK; Han M; Kosciuk MC; Venkataraman V; Zavareh S; Zarrabi S; Kinsler K; Thaker NG; Nagele EP; Dash J; Wang HY; Levitas A
J Alzheimers Dis; 2011; 25(4):605-22. PubMed ID: 21483091
[TBL] [Abstract][Full Text] [Related]
29. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
Bloom GS
JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
[TBL] [Abstract][Full Text] [Related]
30. Commentary: is Alzheimer's disease uniquely human?
Finch CE; Austad SN
Neurobiol Aging; 2015 Feb; 36(2):553-5. PubMed ID: 25533426
[TBL] [Abstract][Full Text] [Related]
31. Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease.
Gouras GK; Almeida CG; Takahashi RH
Neurobiol Aging; 2005 Oct; 26(9):1235-44. PubMed ID: 16023263
[TBL] [Abstract][Full Text] [Related]
32. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
Tomiyama T
Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease.
Griffin WS; Mrak RE
J Leukoc Biol; 2002 Aug; 72(2):233-8. PubMed ID: 12149413
[TBL] [Abstract][Full Text] [Related]
34. Decreased neprilysin immunoreactivity in Alzheimer disease, but not in pathological aging.
Wang DS; Lipton RB; Katz MJ; Davies P; Buschke H; Kuslansky G; Verghese J; Younkin SG; Eckman C; Dickson DW
J Neuropathol Exp Neurol; 2005 May; 64(5):378-85. PubMed ID: 15892294
[TBL] [Abstract][Full Text] [Related]
35. Intraneuronal Aβ as a trigger for neuron loss: can this be translated into human pathology?
Bayer TA; Wirths O
Biochem Soc Trans; 2011 Aug; 39(4):857-61. PubMed ID: 21787313
[TBL] [Abstract][Full Text] [Related]
36. Changes in the expression of genes associated with intraneuronal amyloid-beta and tau in Alzheimer's disease.
Fujimura RK; Reiner T; Ma F; Phillips V; de las Pozas A; Dickson DW; Roos BA; Howard GA; Perez-Stable C
J Alzheimers Dis; 2010; 19(1):97-109. PubMed ID: 20061629
[TBL] [Abstract][Full Text] [Related]
37. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
[TBL] [Abstract][Full Text] [Related]
38. Neuronal loss and beta-amyloid removal in the amygdala of people with Down syndrome.
Weģiel J; Wísniewski HM; Moryś J; Tarnawski M; Kuchna I; Dziewiatkowski J; Pirttilä T; Krivimäki T; Lehtimäki T; Lach B
Neurobiol Aging; 1999; 20(3):259-69. PubMed ID: 10588573
[TBL] [Abstract][Full Text] [Related]
39. Accumulation and age-related elevation of amyloid-β within basal forebrain cholinergic neurons in the rhesus monkey.
Norvin D; Kim G; Baker-Nigh A; Geula C
Neuroscience; 2015 Jul; 298():102-11. PubMed ID: 25869619
[TBL] [Abstract][Full Text] [Related]
40. HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathology.
Barone E; Head E; Butterfield DA; Perluigi M
Free Radic Biol Med; 2017 Oct; 111():262-269. PubMed ID: 27838436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
